2019
DOI: 10.1016/j.etap.2019.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of eNOS/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(25 citation statements)
references
References 44 publications
5
20
0
Order By: Relevance
“…Several interventions have been introduced to halt the pathogenesis of cyclosporine-evoked renal failure; a serious complication during the therapy with cyclosporine in patients with autoimmune diseases and organ transplantation [ 1 , 2 , 3 , 4 ]. The present work suggests that camel milk is a promising natural agent for counteracting cyclosporine-triggered nephrotoxicity.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Several interventions have been introduced to halt the pathogenesis of cyclosporine-evoked renal failure; a serious complication during the therapy with cyclosporine in patients with autoimmune diseases and organ transplantation [ 1 , 2 , 3 , 4 ]. The present work suggests that camel milk is a promising natural agent for counteracting cyclosporine-triggered nephrotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…The dose of cyclosporine and the experimental regimen was based on former studies that demonstrated the marked cyclosporine nephrotoxicity and robust renal inflammation [ 1 , 2 , 19 , 20 ]. Camel milk dose is consistent with former studies that demonstrated the 10 mL/kg dose as an effective dose against several models of inflammation in rats [ 10 , 13 , 14 , 15 , 16 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…From this point of view, nebivolol (NEB) can be a promising therapeutic agent as it has been displayed to have antiinflammatory and anti-apoptotic effects besides its antioxidant properties. 13,14 Nebivolol is a third-generation selective beta-1 receptor antagonist. It is administered orally for the treatment of arterial hypertension owing to its nitric oxide-mediated effects.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the levels of tumor necrosis factor‐alpha (TNF‐α) and other proinflammatory cytokines increase in reperfusion injury; suggesting that anti‐inflammatory agents can be involved more effectively in the prevention of ischemic damage compared to antioxidants. From this point of view, nebivolol (NEB) can be a promising therapeutic agent as it has been displayed to have anti‐inflammatory and anti‐apoptotic effects besides its antioxidant properties 13,14 …”
Section: Introductionmentioning
confidence: 99%